Testing a Peer-led Trauma-focused Intervention for Significant Others of Those With BPD
Starting soon · Phase 1
Conditions studied: Posttraumatic Stress Disorder, Family Members, Spouses
In brief
This project involves developing and piloting a peer-led intervention focused on posttraumatic stress symptoms for the family members and significant others of people with borderline personality disorder. The project involves collaborating with The Sashbear Foundation who will be delivering the trauma response program (TRP) that was developed by the investigative team to its network. In phase 1 of this project, the investigators will evaluate the first delivery of the TRP at The Sashbear Foundation and solicit feedback from peer-facilitators and recipients who consent to research participation. In phase 2 of this project, the investigators will evaluate the efficacy, acceptability, and safety of the delivery of the next two to four TRPs delivered at The Sashbear Foundation consisting of up to approximately 10 group members (maximum number of TRP recipient research participants in phase 2 is 40).
Key facts
- Study ID
- NCT06135090
- Run by
- York University
- People needed
- 60
- Starts
- 2026-10-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Self-identify as having experienced a trauma related to their loved one with BPD or related problems that impacts them
- Has previously received the Family Connections program at Sashbear (i.e., a peer-led intervention that teaches family members skills for managing their relationships with their loved one with BPD and related problems)
You may not qualify if…
- Engagement in suicidal or self-injurious behaviour in the past year
- Elevated BPD symptoms
Where it is running
- York University — Toronto, Ontario, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.